Skip to main content
Caplight Logo









AOBiome Therapeutics Inc.

AOBiome Therapeutics Inc.

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.aobiome.com/

Last Round

Series C

Jan 5, 2017

Total Funding Raised

$30M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AOBiome Therapeutics Inc. is a biotechnology company that develops a novel class of therapeutics for inflammatory conditions, central nervous system disorders, and other systemic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Fashion & Beauty

Business Model

B2B2C

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

live biotherapeuticmicrobiome therapeuticsskin microbiomeinflammatory skin diseaseatopic dermatitiseczema treatmentB244Ammonia Oxidizing BacteriaAOBacne vulgarisrosaceaLBPclinical-stage biotechbacterial therapytopical formulationprurituspharmaceutical licensingcosmetic skin mist

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AOBiome Therapeutics Inc. Comparables

Compare AOBiome Therapeutics Inc. with similar companies based on industry and business-model similarity.

AOBiome Therapeutics Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MatriSys Bioscience
84%
DermBiont
84%
Azitra, Inc.
82%

AOBiome Therapeutics Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJan 5, 2017
VC RoundSep 1, 2015

Key People

Founding team and executive leadership

Jim Hoffman

Chief Operating Officer & Board Member

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 165% MoM, reaching 5.2K.

  • Jun 22, 2026

    Monthly visitors grew 49% MoM.

AOBiome Therapeutics Inc. Filings

Explore SEC and related filing metadata, where available.

AOBiome Therapeutics Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AOBiome Therapeutics Inc.'s valuation, stock price, and market status.

Is AOBiome Therapeutics Inc. a public or private company?

AOBiome Therapeutics Inc. is a private company.

What is the current stock price of AOBiome Therapeutics Inc.?

AOBiome Therapeutics Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is AOBiome Therapeutics Inc. worth (valuation)?

Valuation information for AOBiome Therapeutics Inc. is not publicly available.

Can I buy AOBiome Therapeutics Inc. stock?

AOBiome Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AOBiome Therapeutics Inc.'s last funding round?

AOBiome Therapeutics Inc.'s most recent funding round was Series C on January 5, 2017.

Who are the main investors in AOBiome Therapeutics Inc.?

Investor information for AOBiome Therapeutics Inc. is not publicly disclosed.

Will AOBiome Therapeutics Inc. IPO soon?

No public IPO plans have been announced for AOBiome Therapeutics Inc..

How can I track AOBiome Therapeutics Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AOBiome Therapeutics Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range12
Year Founded2012
Last FundingJan 5, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?